دورية أكاديمية
أعرض في EDS

Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study.

التفاصيل البيبلوغرافية
العنوان: Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study.
المؤلفون: Attauabi M; Department of Gastroenterology and Hepatology, Herlev Hospital, Herlev, Denmark.; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Hvidovre Hospital, Hvidovre, Denmark., Madsen GR; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Hvidovre Hospital, Hvidovre, Denmark.; Gastrounit, Medical Section, Hvidovre Hospital, Hvidovre, Denmark., Bendtsen F; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Hvidovre Hospital, Hvidovre, Denmark.; Gastrounit, Medical Section, Hvidovre Hospital, Hvidovre, Denmark., Wewer AV; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Hvidovre Hospital, Hvidovre, Denmark.; The Paediatric Department, Hvidovre Hospital, Hvidovre, Denmark., Wilkens R; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Hvidovre Hospital, Hvidovre, Denmark.; Gastrounit, Medical Section, Hvidovre Hospital, Hvidovre, Denmark., Ilvemark J; Department of Gastroenterology and Hepatology, Herlev Hospital, Herlev, Denmark., Vladimirova N; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark., Jensen AB; Department of Radiology, Centre for Functional and Diagnostic Imaging and Research, Hvidovre Hospital, Hvidovre, Denmark., Jensen FK; Department of Radiology, Centre for Functional and Diagnostic Imaging and Research, Hvidovre Hospital, Hvidovre, Denmark., Hansen SB; Department of Radiology, Centre for Functional and Diagnostic Imaging and Research, Hvidovre Hospital, Hvidovre, Denmark., Siebner HR; Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Hvidovre Hospital, Hvidovre, Denmark.; Department of Neurology, Bispebjerg Hospital, Kobenhavn, Denmark., Nielsen YJW; Department of Radiology, Herlev Hospital, Herlev, Denmark., Møller JM; Department of Radiology, Herlev Hospital, Herlev, Denmark., Thomsen HS; Department of Radiology, Herlev Hospital, Herlev, Denmark., Thomsen SF; Department of Dermatology, Bispebjerg Hospital, Kobenhavn, Denmark., Ingels HAS; Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital, Kobenhavn, Denmark., Theede K; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Hvidovre Hospital, Hvidovre, Denmark.; Gastrounit, Medical Section, Hvidovre Hospital, Hvidovre, Denmark., Boysen T; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Hvidovre Hospital, Hvidovre, Denmark.; Gastrounit, Medical Section, Hvidovre Hospital, Hvidovre, Denmark., Bjerrum JT; Department of Gastroenterology and Hepatology, Herlev Hospital, Herlev, Denmark., Jakobsen C; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Hvidovre Hospital, Hvidovre, Denmark.; The Paediatric Department, Hvidovre Hospital, Hvidovre, Denmark., Dorn-Rasmussen M; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Hvidovre Hospital, Hvidovre, Denmark.; The Paediatric Department, Hvidovre Hospital, Hvidovre, Denmark., Jansson S; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Hvidovre Hospital, Hvidovre, Denmark.; The Paediatric Department, Hvidovre Hospital, Hvidovre, Denmark., Yao Y; Department of Dermatology, Bispebjerg Hospital, Kobenhavn, Denmark., Burian EA; Department of Dermatology, Bispebjerg Hospital, Kobenhavn, Denmark., Møller FT; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Kobenhavn, Denmark., Fana V; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Kobenhavn, Denmark., Wiell C; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Kobenhavn, Denmark., Terslev L; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup, Glostrup, Denmark., Østergaard M; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Kobenhavn, Denmark., Bertl K; Department of Periodontology, Malmö Universitet, Malmo, Sweden., Stavropoulos A; Malmo Universitet, Malmo, Sweden.; Division of Conservative Dentistry and Periodontology, University Clinic of Dentistry, Medical University of Vienna, Vienna, Austria., Seidelin JB; Department of Gastroenterology and Hepatology, Herlev Hospital, Herlev, Denmark., Burisch J; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Hvidovre Hospital, Hvidovre, Denmark johan.burisch@regionh.dk.; Gastrounit, Medical Section, Hvidovre Hospital, Hvidovre, Denmark.
المصدر: BMJ open [BMJ Open] 2022 Jun 27; Vol. 12 (6), pp. e055779. Date of Electronic Publication: 2022 Jun 27.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : BMJ Publishing Group Ltd, 2011-
مواضيع طبية MeSH: Colitis, Ulcerative*/therapy , Inflammatory Bowel Diseases*/diagnosis , Microbiota*, Adolescent ; Adult ; Child ; Cohort Studies ; Humans ; Prognosis ; Prospective Studies ; Quality of Life
مستخلص: Introduction: Inflammatory bowel diseases (IBD), encompassing Crohn's disease and ulcerative colitis, are chronic, inflammatory diseases of the gastrointestinal tract. We have initiated a Danish population-based inception cohort study aiming to investigate the underlying mechanisms for the heterogeneous course of IBD, including need for, and response to, treatment.
Methods and Analysis: IBD Prognosis Study is a prospective, population-based inception cohort study of unselected, newly diagnosed adult, adolescent and paediatric patients with IBD within the uptake area of Hvidovre University Hospital and Herlev University Hospital, Denmark, which covers approximately 1 050 000 inhabitants (~20% of the Danish population). The diagnosis of IBD will be according to the Porto diagnostic criteria in paediatric and adolescent patients or the Copenhagen diagnostic criteria in adult patients. All patients will be followed prospectively with regular clinical examinations including ileocolonoscopies, MRI of the small intestine, validated patient-reported measures and objective examinations with intestinal ultrasound. In addition, intestinal biopsies from ileocolonoscopies, stool, rectal swabs, saliva samples, swabs of the oral cavity and blood samples will be collected systematically for the analysis of biomarkers, microbiome and genetic profiles. Environmental factors and quality of life will be assessed using questionnaires and, when available, automatic registration of purchase data. The occurrence and course of extraintestinal manifestations will be evaluated by rheumatologists, dermatologists and dentists, and assessed by MR cholangiopancreatography, MR of the spine and sacroiliac joints, ultrasonography of peripheral joints and entheses, clinical oral examination, as well as panoramic radiograph of the jaws. Fibroscans and dual-energy X-ray absorptiometry scans will be performed to monitor occurrence and course of chronic liver diseases, osteopenia and osteoporosis.
Ethics and Dissemination: This study has been approved by Ethics Committee of the Capital Region of Denmark (approval number: H-20065831). Study results will be disseminated through publication in international scientific journals and presentation at (inter)national conferences.
Competing Interests: Competing interests: HRS: HRS has received honoraria as speaker from Sanofi Genzyme, Denmark and Novartis, Denmark, as consultant from Sanofi Genzyme, Denmark, Lophora, Denmark, and Lundbeck AS, Denmark, and as editor-in-chief (Neuroimage Clinical) and senior editor (NeuroImage) from Elsevier Publishers, Amsterdam, The Netherlands. He has received royalties as book editor from Springer Publishers, Stuttgart, Germany and from Gyldendal Publishers, Copenhagen, Denmark. JBS: Has received unrestricted research grants from Janssen and Takeda and is national coordinator of clinical trials from Boerhinger Ingelheim and Eli Lilly. JB: Personal fees from AbbVie, Janssen-Cilag, Celgene, Samsung Bioepis, and Pfizer; grants and personal fees from Takeda, MSD, and Tillots Pharma; grants from Novo Nordisk Foundation and Bristol Meyers Squibb.
(© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
References: J Crohns Colitis. 2019 Feb 01;13(2):198-208. (PMID: 30289522)
J Crohns Colitis. 2016 Jan;10(1):20-5. (PMID: 26438714)
Euro Surveill. 2018 Jun;23(24):. (PMID: 29921346)
Inflamm Bowel Dis. 2022 May 12;:. (PMID: 35552410)
J Rheumatol. 2013 Oct;40(10):1726-35. (PMID: 23996291)
J Periodontol. 2018 Jun;89 Suppl 1:S74-S84. (PMID: 29926944)
J Clin Periodontol. 2018 Jul;45(7):818-831. (PMID: 29611224)
J Biomed Inform. 2009 Apr;42(2):377-81. (PMID: 18929686)
Gut. 2019 Mar;68(3):423-433. (PMID: 29363534)
World J Gastroenterol. 2012 Nov 7;18(41):5848-61. (PMID: 23139600)
J Clin Periodontol. 2017 Apr;44(4):382-393. (PMID: 28117909)
PLoS One. 2014 Feb 04;9(2):e87991. (PMID: 24505344)
Gut. 2017 Apr;66(4):588-596. (PMID: 26646934)
Gut. 2020 Sep;69(9):1629-1636. (PMID: 31862811)
Inflamm Bowel Dis. 2009 May;15(5):742-9. (PMID: 19023861)
Aliment Pharmacol Ther. 2019 Jul;50(1):33-39. (PMID: 31069829)
J Crohns Colitis. 2016 Apr;10(4):455-61. (PMID: 26721937)
Gut. 1998 Jul;43(1):29-32. (PMID: 9771402)
Expert Rev Gastroenterol Hepatol. 2021 Jul 19;:1-15. (PMID: 34227446)
JCI Insight. 2021 Dec 8;6(23):. (PMID: 34710061)
Am J Gastroenterol. 2013 Jan;108(1):106-12. (PMID: 23229423)
Aliment Pharmacol Ther. 2017 Mar;45(6):814-823. (PMID: 28105709)
Lancet. 1980 Mar 8;1(8167):514. (PMID: 6102236)
Gastroenterology. 2002 Feb;122(2):512-30. (PMID: 11832465)
Therap Adv Gastroenterol. 2021 Apr 16;14:17562848211006672. (PMID: 33948115)
J Dent Res. 2020 Aug;99(9):1021-1029. (PMID: 32464078)
J Clin Periodontol. 2018 Jun;45 Suppl 20:S278-S285. (PMID: 29926496)
Inflamm Bowel Dis. 2011 Jun;17(6):1314-21. (PMID: 21560194)
Am J Gastroenterol. 2011 Jan;106(1):110-9. (PMID: 20808297)
Gastroenterology. 1996 Feb;110(2):424-31. (PMID: 8566589)
Aliment Pharmacol Ther. 2011 Dec;34(11-12):1328-36. (PMID: 21999576)
Dan Med J. 2018 Nov;65(11):. (PMID: 30382020)
Am J Gastroenterol. 2001 Oct;96(10):2921-8. (PMID: 11693327)
J Pediatr Gastroenterol Nutr. 2002 Oct;35(4):557-63. (PMID: 12394384)
Biomed Res Int. 2021 Mar 12;2021:6692420. (PMID: 33778080)
J Periodontal Res. 2017 Jun;52(3):313-324. (PMID: 27663744)
Nat Rev Gastroenterol Hepatol. 2013 Oct;10(10):585-95. (PMID: 23835489)
J Crohns Colitis. 2019 Feb 1;13(2):144-164. (PMID: 30137275)
Aliment Pharmacol Ther. 2017 Apr;45(7):961-972. (PMID: 28229470)
Nat Microbiol. 2017 Feb 13;2:17004. (PMID: 28191884)
J Crohns Colitis. 2021 Apr 6;15(4):609-616. (PMID: 33098642)
Br J Dermatol. 2018 Jan;178(1):222-228. (PMID: 28667743)
Gastroenterology. 2007 Feb;132(2):763-86. (PMID: 17258735)
Gastroenterology. 2006 Mar;130(3):650-6. (PMID: 16530505)
Therap Adv Gastroenterol. 2018 May 01;11:1756284818771367. (PMID: 29881463)
Inflamm Bowel Dis. 2015 Aug;21(8):1794-800. (PMID: 26020601)
Aliment Pharmacol Ther. 2018 Jan;47(1):26-42. (PMID: 29034981)
Clin Gastroenterol Hepatol. 2019 Dec;17(13):2704-2712.e3. (PMID: 30936024)
Gut. 2015 Jul;64(7):1063-71. (PMID: 25217388)
Nat Rev Dis Primers. 2020 Sep 10;6(1):74. (PMID: 32913180)
Inflamm Bowel Dis. 2017 Jan;23(1):143-151. (PMID: 27930407)
J Clin Periodontol. 2018 Jun;45 Suppl 20:S149-S161. (PMID: 29926495)
Nat Rev Dis Primers. 2020 Apr 2;6(1):22. (PMID: 32242028)
Gastroenterology. 2021 Jul;161(1):47-65. (PMID: 33940007)
Gastroenterology. 2007 Aug;133(2):423-32. (PMID: 17681163)
Acta Odontol Scand. 2021 Jul;79(5):344-353. (PMID: 33370548)
Dan Med J. 2014 Jan;61(1):B4778. (PMID: 24393595)
BMJ Open Gastroenterol. 2018 May 31;5(1):e000208. (PMID: 29915667)
Inflamm Bowel Dis. 2010 Dec;16(12):2131-6. (PMID: 20848462)
Health Policy. 1990 Dec;16(3):199-208. (PMID: 10109801)
Gastroenterology. 2005 Sep;129(3):827-36. (PMID: 16143122)
Am J Gastroenterol. 2001 Apr;96(4):1116-22. (PMID: 11316157)
Inflamm Bowel Dis. 2021 May 17;27(6):927-939. (PMID: 32628745)
J Crohns Colitis. 2021 Sep 25;15(9):1573-1587. (PMID: 33582812)
Arthritis Rheum. 2009 May 15;61(5):658-66. (PMID: 19405003)
J Crohns Colitis. 2017 Sep 01;11(9):1078-1084. (PMID: 28430891)
BMC Oral Health. 2020 Mar 12;20(1):67. (PMID: 32164696)
J Pediatr Gastroenterol Nutr. 2003 Jan;36(1):90-5. (PMID: 12500002)
J Crohns Colitis. 2016 Dec;10(12):1385-1394. (PMID: 27282402)
Int J Environ Res Public Health. 2021 Nov 02;18(21):. (PMID: 34770034)
فهرسة مساهمة: Keywords: Adult gastroenterology; EPIDEMIOLOGY; IMMUNOLOGY; Inflammatory bowel disease; MOLECULAR BIOLOGY; Paediatric gastroenterology
تواريخ الأحداث: Date Created: 20220627 Date Completed: 20220629 Latest Revision: 20220716
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9237907
DOI: 10.1136/bmjopen-2021-055779
PMID: 35760545
قاعدة البيانات: MEDLINE
الوصف
تدمد:2044-6055
DOI:10.1136/bmjopen-2021-055779